We’ve Booked Nearly 200% on This Must-Own Company

Article was originally posted here

The Four Tops released their second album in 1965, including what would become one of their most enduring tracks, “It’s the Same Old Song.”

I’ll bet dimes to dollars you know at least a few bars – even if you’re not a Motown fan.

The refrain, in particular…

“Now it’s the same old song, but with a different meaning since you been gone…”

The Four Tops created, recorded, and released the tune in less than 24 hours. According to tenor Abdul “Duke” Fakir, it was produced as a “sound-alike,” intended to capitalize on similar success.

To that end, you can’t help but wonder about its longevity on a day like today, when two of three major averages are “red”… and everything sounds alike.

As I type, a quick glance at the headlines tells me the Street is worried about a global slowdown, the U.S. shutdown and housing markets, turmoil in Venezuela, Brexit – you name it.

Those risks are always out there; it’s the same old song.

As in, there’s always going to be the risk of slowdown, geopolitical strife and war, uncertainty, of your getting hit by a bus right after you fall out of bed.

OK – I made that last one up… but you get my point.

Worrying about what might happen is normal. It’s part of the human experience because the perception of fear is immediately related to the issue of risk – or at least that’s what the scientists say.

Only – and this is the important part – perceptions of risk rarely relate to reality.

The world’s best investors know this.

And of course, so do we.

Which is why, of course, we want to constantly be on the lookout for hugely profitable opportunities others can’t process because their fears are holding them back.

Opportunities like the one I’m going to share with you right now…

This Has Been a Huge Winner for My Subscribers

Take Masimo Corp. (NASDAQ: MASI), for instance.

BE THERE! On Jan. 31 at 1 p.m. sharp, Keith is unveiling a brand-new, NASA-derived technology that could help make you $240,000 richer in 2019. Click here to save your FREE spot in the big reveal

The stock is up 189% since I recommended it on July 21, 2015. By comparison, the S&P 500 is up just 28.5% in the same time period.

In plain English, that means:

  • MASI has delivered a very healthy 7:1 performance advantage over the general markets.
  • Savvy investors who are following along as directed have had the opportunity to turn every $10,000 into at least $21,185 versus just $12,602 by “buying the index.”

That’s an extra $8,583 in your pocket on every $10,000.

I don’t know too many investors who can throw that away.

Ever.

That’s just the story so far. Because Masimo is still a fantastic buy, with plenty of upside left to run, I’m sharing the recommendation with everyone today.

Here’s what you need to know…

Masimo Has a Lock on a Growing Niche

The company develops, manufactures, and markets non-invasive monitoring solutions used in hospital settings through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring.

$240,000 Richer: This NASA-derived tech could give regular folks to chance to pocket six-figure windfalls – $146,010, $171,877, $216,985, $254,078. Click here to get your FREE spot at the big online reveal at 1 p.m. on Jan. 31

Earlier this week, on Tuesday, Jan. 22, the company announced the U.S. launch of Iris Device Management System (Iris DMS), an automation and connectivity solution designed to streamline management of Masimo devices used throughout a hospital system.

According to Masimo…

Iris DMS is designed to address the challenges of maintaining many patient monitors in a complex hospital environment. Iris DMS securely connects over a hospital’s existing network to all connected Masimo devices to provide an easy-to-use dashboard that allows Biomedical Engineers and IT professionals to view detailed diagnostic information about connected Masimo devices at a glance, without the need to physically interact with each device.

From 2015 to 2017, revenue grew 37.59%, from $580 million to $798.1 million. Over the same period, net income grew 332.47%, from $72.52 million to $131.62 million.

I think that’s a drop in the proverbial bucket, given how fast our world is “aging” and the rapidly growing need for complicated medical data that will help keep us healthy.

That’s an irresistible opportunity, so this is the perfect time to pick up shares of MASI. I recommend using your speculative capital to do so. In my original Money Map Report recommendation, I put these shares squarely in the “Rocket Riders” portion of our risk-balanced portfolio – the “10” in our proprietary 50-40-10 portfolio structure (Note: You can click here to learn more about how Keith’s “Money Map Method” works.)

Has the Stock Market Stopped Making Sense to You?

One day, good companies are tumbling while shoddy ones soar for no reason. The next day, the opposite occurs. Up, down, up, down. Wall Street seems trapped in a perpetual cycle of chaos.

But this isn’t random. It’s part of a bigger game that’s being played – a game of supercomputers executing billions of algorithmic trades a day – creating MASSIVE price imbalances in stocks. But now a NASA-based technology can uncover these massive opportunities – and it could help you turn this mayhem into single-stock windfalls of $190,380… $242,174… $282,965… even $405,511 – over and over again! [Continue reading…]

Follow Money Morning onFacebook, Twitter, and LinkedIn.

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.

Disclaimer: © 2019 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.

This post is from MoneyMorning. We encourage our readers to continue reading the full article from the original source here.